WallStreetZenWallStreetZen

NASDAQ: BLRX
Biolinerx Ltd Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

BLRX earnings and revenue history

Current Revenue
$4.8M
Current Earnings
-$60.6M
Current Profit Margin
-1,262.8%

BLRX Return on Equity

Current Company
-280.2%
Current Industry
-63.5%
Current Market
188%
BLRX's Return on Equity (-280.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BLRX announces earnings.

BLRX Return on Assets

Current Company
-99.2%
Current Industry
2.9%
BLRX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BLRX Return on Capital Employed

Current Company
-176.72%
Current Industry
19.5%
BLRX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BLRX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BLRX$4.80M-$57.06M-$60.61MN/AN/A
IMRX$0.00-$52.71M-$53.47M-100.00%N/A
APLM$0.00-$171.77M-$172.60MN/AN/A
AADI$24.35M-$64.90M-$65.77M+3.85%N/A
OCEA$0.00-$97.33M-$98.59MN/AN/A
View Top Biotech Stocks

BLRX earnings dates

Next earnings date
May 22, 2024

Biolinerx Earnings & Revenue FAQ

What were BLRX's earnings last quarter?

On Invalid Date, Biolinerx (NASDAQ: BLRX) reported Q4 2023 earnings per share (EPS) of -$0.01, up Infinity% year over year. Total Biolinerx earnings for the quarter were -$13.88 million. In the same quarter last year, Biolinerx's earnings per share (EPS) was $0.00.

If you're new to stock investing, here's how to buy Biolinerx stock.

What was BLRX's earnings growth in the past year?

As of Q2 2024, Biolinerx's earnings has grown year over year. Biolinerx's earnings in the past year totalled -$60.61 million.

What is BLRX's earnings date?

Biolinerx's earnings date is Invalid Date. Add BLRX to your watchlist to be reminded of BLRX's next earnings announcement.

What was BLRX's revenue last quarter?

On Invalid Date, Biolinerx (NASDAQ: BLRX) reported Q4 2023 revenue of $4.80 million up Infinity% year over year. In the same quarter last year, Biolinerx's revenue was $0.00.

What was BLRX's revenue growth in the past year?

As of Q2 2024, Biolinerx's revenue has grown null year over year. Biolinerx's revenue in the past year totalled $4.80 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.